For some, the issue with GLP-1 drugs like Ozempic and Mounjaro isn't getting access to these game-changing medications, but ...
But for a long time China’s people struggled to get hold of Wegovy because the country’s regulators had not approved it. Some ...
2d
Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic ...
More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each ...
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump ...
It would give millions of people access to weekly injectables that have helped people shed pounds so quickly that some people ...
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...
Clinical trials show that around one in ten people are ‘non-responders’. Outside of trials, that figure might be much higher.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback